CLEERPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CLEERPHARMA
Largest movements
- Cash +€192,835
up €192,835 (+56.4%), from €341,853 to €534,688
mainly Net result for the year (+€317,779) and Depreciation (+€20,238)
- Receivables within one year +€113,314
up €113,314 (+1621.7%), from €6,987 to €120,301
of which Trade receivables: +€115,092
- Reserves +€315,000
up €315,000 (+22.8%), from €1.4m to €1.7m
of which Tax-exempt reserves: +€315,000
- Trade debts -€25,270
down €25,270 (-13.7%), from €184,512 to €159,242
- Debts after one year -€20,913
down €20,913 (-39.5%), from €52,884 to €31,971
- Gross operating margin +€154,677
up €154,677 (+44.3%), from €349,132 to €503,810
- Financial income -€36,880
down €36,880 (-52.6%), from €70,114 to €33,234
- Taxes +€36,381
up €36,381 (+33.2%), from €109,574 to €145,955
- Staff costs +€7,453
up €7,453 (+18.8%), from €39,613 to €47,066
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,730,347 | €2,017,321 | +€286,974 | +16.6% |
| Fixed assets | 21/28 | €307,438 | €295,342 | -€12,096 | -3.9% |
| Tangible fixed assets | 22/27 | €307,438 | €295,342 | -€12,096 | -3.9% |
| Land and buildings | 22 | €269,366 | €267,220 | -€2,146 | -0.8% |
| Furniture and vehicles | 24 | €1,263 | €2,431 | +€1,168 | +92.5% |
| Other tangible fixed assets | 26 | €36,809 | €25,690 | -€11,119 | -30.2% |
| Current assets | 29/58 | €1,422,909 | €1,721,979 | +€299,070 | +21.0% |
| Stocks and contracts in progress | 3 | €59,568 | €71,420 | +€11,851 | +19.9% |
| Stocks | 30/36 | €59,568 | €71,420 | +€11,851 | +19.9% |
| Amounts receivable within one year | 40/41 | €6,987 | €120,301 | +€113,314 | +1621.7% |
| Trade receivables | 40 | €5,209 | €120,301 | +€115,092 | +2209.6% |
| Other amounts receivable | 41 | €1,779 | - | -€1,779 | |
| Current investments | 50/53 | €1,011,429 | €991,429 | -€20,000 | -2.0% |
| Cash at bank and in hand | 54/58 | €341,853 | €534,688 | +€192,835 | +56.4% |
| Deferred charges and accrued income | 490/1 | €3,072 | €4,142 | +€1,070 | +34.8% |
| Total equity and liabilities | 10/49 | €1,730,347 | €2,017,321 | +€286,974 | +16.6% |
| Equity | 10/15 | €1,447,662 | €1,765,441 | +€317,779 | +22.0% |
| Contributions | 10/11 | €48,474 | €48,474 | = | 0.0% |
| Reserves | 13 | €1,380,000 | €1,695,000 | +€315,000 | +22.8% |
| Tax-exempt reserves | 132 | €710,000 | €1,025,000 | +€315,000 | +44.4% |
| Distributable reserves | 133 | €670,000 | €670,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €19,188 | €21,967 | +€2,779 | +14.5% |
| Amounts payable | 17/49 | €282,685 | €251,879 | -€30,805 | -10.9% |
| Amounts payable after more than one year | 17 | €52,884 | €31,971 | -€20,913 | -39.5% |
| Financial debts | 170/4 | €52,884 | €31,971 | -€20,913 | -39.5% |
| Amounts payable within one year | 42/48 | €229,801 | €219,908 | -€9,893 | -4.3% |
| Current portion of amounts payable after more than one year | 42 | €20,597 | €20,913 | +€315 | +1.5% |
| Trade debts | 44 | €184,512 | €159,242 | -€25,270 | -13.7% |
| Suppliers | 440/4 | €184,512 | €159,242 | -€25,270 | -13.7% |
| Taxes, remuneration and social security | 45 | €23,538 | €39,754 | +€16,216 | +68.9% |
| Taxes | 450/3 | €15,255 | €31,999 | +€16,744 | +109.8% |
| Remuneration and social security | 454/9 | €8,283 | €7,755 | -€528 | -6.4% |
| Other amounts payable | 47/48 | €1,154 | - | -€1,154 | |
| Non-recurring operating income | 76A | - | €26,697 | +€26,697 | |
| Remuneration, social security and pensions | 62 | €39,613 | €47,066 | +€7,453 | +18.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €21,047 | €20,238 | -€809 | -3.8% |
| Other operating charges | 640/8 | €4,953 | €5,173 | +€221 | +4.5% |
| Gross operating margin | 9900 | €349,132 | €503,810 | +€154,677 | +44.3% |
| Operating profit (loss) | 9901 | €283,520 | €431,332 | +€147,813 | +52.1% |
| Financial income | 75/76B | €70,114 | €33,234 | -€36,880 | -52.6% |
| Recurring financial income | 75 | €70,114 | €33,234 | -€36,880 | -52.6% |
| Financial charges | 65/66B | €1,547 | €833 | -€714 | -46.2% |
| Recurring financial charges | 65 | €1,547 | €833 | -€714 | -46.2% |
| Profit (loss) for the period before taxes | 9903 | €352,087 | €463,734 | +€111,647 | +31.7% |
| Income taxes | 67/77 | €109,574 | €145,955 | +€36,381 | +33.2% |
| Profit (loss) for the period | 9904 | €242,513 | €317,779 | +€75,266 | +31.0% |
| Profit (loss) for the period to be appropriated | 9905 | €242,513 | €317,779 | +€75,266 | +31.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.